Rudolf, M., Geddes, D. M., Turner, J. A. McM., and Saunders, K. B. (1978) . Thorax, 33, [97] [98] [99] [100] . Depression of central respiratory drive by nitrazepam. In a group of patients with chronic bronchitis, repeated night sedation with 10 mg nitrazepam produced a fall in central respiratory drive and a steady rise in arterial carbon dioxide tension. The changes produced over a five-day period were not clinically important, except in two patients who were already hypercapnic before receiving nitrazepam. The use of this drug in patients with carbon dioxide retention should be avoided.
Nitrazepam (Mogadon), a benodiazepine, is now regarded as the hypnotic of choice in this country (British Medical Journal, 1976) . There have been several case reports of the apparent precipitation by nitrazepam of respiratory failure in patients with pre-existing pulmonary disease (Clark et al., 1971; Hilton, 1971;  Pines, 1972; Model, 1973) , but the mechanism of this respiratory depression is unclear (Gaddie et al., 1972) .
We have shown that a single 5-mg dose of nitrazepam fails to produce any significant depression of central respiratory drive (as assessed by the ventilatory response to carbon dioxide) either in subjects without lung disease or in patients with chronic bronchitis (Geddes et al., 1976) . Since repeated administration of nitrazepam at 24-hour intervals is known to produce a steady rise in plasma levels of the drug over the first four to five days (Reider and Wendt, 1973) , cumulative effects might be anticipated. We is a rapid and easily performed method of assessing the effects of drugs on the respiratory control system and, as long as lung mechanics remain constant, any change in this response represents a change in central drive. Opiates, barbiturates, and other benzodiazepines have been shown to depress central respiratory drive using this technique (Gasser et al., 1975; Weil et al., 1975; Gasser and Bellville, 1976; Geddes et al., 1976) . The steady decrease in mean C02 response over the five days of the study suggests that nitrazepam-induced suppression of ventilatory drive is a cumulative effect. However, whereas this fall in C02 sensitivity did not attain statistical significance until the fifth day, the increase in mean Paco2 was statistically significant by day 1. Although this can be explained by the greater variance of the former measurement, it does raise the possibility that something other than depression of respiratory drive might have been causing these changes in Paco2.
Two possible explanations are (1) that Paco2 may have risen as a result of increasing maldistribution of ventilation :perfusion ratios throughout the lung (West, 1963) , and there is some evidence that diazepam, another benzodiazepine, can cause this Kafer, 1971a, 1971 b), and (2) that the respiratory depression may have been produced, not by an effect on central drive, but by the known ability of benzodiazepine drugs to cause muscle relaxation and consequent impairment of ventilatory capacity (Gaddie et al., 1972; Model and Berry, 1974) . The absence of any significant changes in either Pao2 or FEV1 in our study argues against both these possibilities, and we believe that the increase in Paco2 that we observed was most likely due to the decrease in central drive rather than to any other cause.
Although sedatives and hypnotics are generally considered always to be contraindicated in patients with acute respiratory failure, their position in the treatment of patients with chronic stable respiratory failure is less certain. It is often tempting to use such drugs, especially when nocturnal dyspnoea and insomnia are problems, and, in the absence of any previously proven respiratory depressant effect, nitrazepam has been assumed to be comparatively safe in these circumstances. We feel that the results 99 of this study make this assumption no longerjustified, and that the presence of chronic hypercapnia should make one strongly resist the temptation to prescribe nitrazepam or any other hypnotic.
The chronic bronchitics with normal arterial Pco2 showed blood gas changes which, although statistically significant, were 
